These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 17383998)

  • 1. The retinal tolerance to bevacizumab in co-application with a recombinant tissue plasminogen activator.
    Lüke M; Januschowski K; Warga M; Beutel J; Leitritz M; Gelisken F; Grisanti S; Schneider T; Lüke C; Bartz-Schmidt KU; Szurman P;
    Br J Ophthalmol; 2007 Aug; 91(8):1077-82. PubMed ID: 17383998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of bevacizumab on retinal function in isolated vertebrate retina.
    Lüke M; Warga M; Ziemssen F; Gelisken F; Grisanti S; Schneider T; Lüke C; Partsch M; Bartz-Schmidt KU; Szurman P;
    Br J Ophthalmol; 2006 Sep; 90(9):1178-82. PubMed ID: 16754646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of ranibizumab (Lucentis) on retinal function in isolated perfused vertebrate retina.
    Lüke M; Januschowski K; Lüke J; Peters S; Wirtz N; Yörük E; Lüke C; Bartz-Schmidt KU; Grisanti S; Szurman P
    Br J Ophthalmol; 2009 Oct; 93(10):1396-400. PubMed ID: 19628500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of triamcinolone crystals on retinal function in a model of isolated perfused vertebrate retina.
    Lüke M; Januschowski K; Beutel J; Warga M; Grisanti S; Peters S; Schneider T; Lüke C; Bartz-Schmidt KU; Szurman P
    Exp Eye Res; 2008 Jul; 87(1):22-9. PubMed ID: 18514644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of bevacizumab (Avastin®) on the electroretinogram of isolated rat retina.
    Cia D; Cluzel J; Jacquemot N; Doly M
    Ophthalmic Res; 2011; 46(3):145-51. PubMed ID: 21372616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subretinal coapplication of recombinant tissue plasminogen activator and bevacizumab for neovascular age-related macular degeneration with submacular haemorrhage.
    Treumer F; Klatt C; Roider J; Hillenkamp J
    Br J Ophthalmol; 2010 Jan; 94(1):48-53. PubMed ID: 19946027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiological toxicity testing of VEGF Trap-Eye in an isolated perfused vertebrate retina organ culture model.
    Januschowski K; Schnichels S; Hagemann U; Koch V; Hofmann J; Spitzer MS; Bartz-Schmidt KU; Szurman P; Lüke M; Aisenbrey S
    Acta Ophthalmol; 2014 Jun; 92(4):e305-11. PubMed ID: 24206925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compatibility of recombinant tissue plasminogen activator and bevacizumab co-applied for neovascular age-related macular degeneration with submacular hemorrhage.
    Klettner A; Puls S; Treumer F; Roider J; Hillenkamp J
    Arch Ophthalmol; 2012 Jul; 130(7):875-881. PubMed ID: 22410628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased electroretinogram a-wave amplitude after intravitreal bevacizumab injection for neovascular age-related macular degeneration.
    Skaat A; Solomon A; Moroz I; Hai OV; Rechtman E; Vishnevskia Dai V; Rotenstreich Y
    Acta Ophthalmol; 2011 May; 89(3):e269-73. PubMed ID: 20946333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined treatment of acute subretinal haemorrhages with intravitreal recombined tissue plasminogen activator, expansile gas and bevacizumab: a retrospective pilot study.
    Meyer CH; Scholl HP; Eter N; Helb HM; Holz FG
    Acta Ophthalmol; 2008 Aug; 86(5):490-4. PubMed ID: 18221499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing the effects of two different irrigation solutions on an isolated perfused vertebrate retina.
    Januschowski K; Maddani R; Mueller S; Lueke M; Spitzer MS; Schultheiss M; Bartz-Schmidt KU; Szurman P
    Ophthalmic Res; 2012; 48(2):59-66. PubMed ID: 22472946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreous injection of bevacizumab, tissue plasminogen activator, and gas in the treatment of submacular hemorrhage in age-related macular degeneration.
    Guthoff R; Guthoff T; Meigen T; Goebel W
    Retina; 2011 Jan; 31(1):36-40. PubMed ID: 20921929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the protein tyrosine kinase inhibitor genistein and taurine on retinal function in isolated superfused retina.
    Lüke M; Krott R; Warga M; Szurman P; Grisanti S; Bartz-Schmidt KU; Schneider T; Lüke C
    Graefes Arch Clin Exp Ophthalmol; 2007 Feb; 245(2):242-8. PubMed ID: 16453129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcome of subretinal coapplication of rtPA and bevacizumab followed by repeated intravitreal anti-VEGF injections for neovascular AMD with submacular haemorrhage.
    Treumer F; Roider J; Hillenkamp J
    Br J Ophthalmol; 2012 May; 96(5):708-13. PubMed ID: 22174095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of daunorubicin and CD95L on retinal function in superfused vertebrate retina.
    Hueber A; Lüke M; Esser PJ; Kirchhof B; Sickel W; Lüke C
    J Ocul Pharmacol Ther; 2005 Apr; 21(2):133-8. PubMed ID: 15857279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating short-term toxicity of melphalan in a model of an isolated and superfused bovine retina.
    Januschowski K; Krupp C; Mueller S; Hofmann K; Schnichels S; Hagemann U; Spitzer MS; Bartz-Schmidt KU; Aisenbrey S
    Graefes Arch Clin Exp Ophthalmol; 2016 Jan; 254(1):91-6. PubMed ID: 26335534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The intravitreal application of the tissue plasminogen activator in the treatment of submacular hemorrhage--a case report].
    Fric E; Sín M; Rehák M; Chrapek O; Simicák J; Fehák J
    Cesk Slov Oftalmol; 2008 Nov; 64(6):237-40. PubMed ID: 19110965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of protein tyrosine kinase inhibitor genistein on retinal function in superfused vertebrate retina.
    Lüke C; Krott R; Lüke M; Lebek J; Walter P; Brunner R; Sickel W
    J Ocul Pharmacol Ther; 2001 Apr; 17(2):151-8. PubMed ID: 11324982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophysiological effects of Brilliant Blue G in the model of the isolated perfused vertebrate retina.
    Lüke M; Januschowski K; Beutel J; Lüke C; Grisanti S; Peters S; Jaissle GB; Bartz-Schmidt KU; Szurman P
    Graefes Arch Clin Exp Ophthalmol; 2008 Jun; 246(6):817-22. PubMed ID: 18197412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pars plana vitrectomy, subretinal injection of recombinant tissue plasminogen activator and fluid-gas exchange in the management of massive submacular hemorrhages secondary to age-related macular degeneration].
    Auriol S; Mahieu L; Lequeux L; Quintyn JC; Pagot-Mathis V
    J Fr Ophtalmol; 2010 Feb; 33(2):84-91. PubMed ID: 20092910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.